Achilles Therapeutics plc(ACHL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ACHL Achilles Therapeutics plc

Pre-Market Trading 05-03 07:01:55 EDT

0.7800

-0.0018

-0.23%

High0.8090	Low0.7600	Vol163.35K
Open0.7900	D1 Closing0.7818	Amplitude6.27%
Mkt Cap32.04M	Tradable Cap16.54M	Total Shares41.08M
T/O127.78K	T/O Rate0.77%	Tradable Shares21.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ACHL","market":"US","secType":"STK","nameCN":"Achilles Therapeutics plc","latestPrice":0.78,"timestamp":1714680000000,"preClose":0.7818,"halted":0,"volume":163349,"delay":0,"floatShares":21210020,"shares":41082948,"eps":-1.742798,"marketStatus":"Pre-Market Trading","change":-0.0018,"latestTime":"05-03 07:01:55 EDT","open":0.79,"high":0.809,"low":0.76,"amount":127777.5827083,"amplitude":0.062676,"askPrice":0.8479,"askSize":274,"bidPrice":0.6951,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.742798,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1714743000000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1617163200000,"exchange":"NASDAQ","adjPreClose":0.7801,"postHourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.78,"latestTime":"17:17 EDT","volume":51,"amount":39.7518,"timestamp":1714684657359},"volumeRatio":0.660368433967544},"requestUrl":"/m/hq/s/ACHL","defaultTab":"news","newsList":[{"id":"2425871341","title":"Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2425871341","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2425871341?lang=en_us&edition=fundamental","pubTime":"2024-04-05 02:39","pubTimestamp":1712255989,"startTime":"0","endTime":"0","summary":"U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday.\n\nThe Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&amp;P 500 also fell, dropping, 0.28% to 5,197.03.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38098514/dow-dips-over-200-points-rpm-international-shares-fall-after-q3-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2425723310","title":"BRNS, UPC and KWE among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2425723310","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2425723310?lang=en_us&edition=fundamental","pubTime":"2024-04-05 01:06","pubTimestamp":1712250403,"startTime":"0","endTime":"0","summary":"Gainers: Allurion Technologies  +107%. Candel Therapeutics  +93%. TC BioPharm plc  +62%. HWH International  +47%. Barinthus Biotherapeutics Plc.  +41%. Eiger BioPharmaceuticals  +37%. Macrogenics  +33%. E-Home Household Service Holdings Ltd  +30%. Niu Technologies  +27%.  Sportsman's Warehouse Holdings  +24%.  Losers: eFFECTOR Therapeutics  -81%. AXT  -25%. Achilles Therapeutics Plc  -24%. Keyarch Acquisition Corp  -23%. KWESST Micro Systems  -22%. Lamb Weston Holdings  -19%. XTI Aerospace  -18%. Inotiv  -18%. Universe Pharmaceuticals  -18%. Riley Exploration Permian  -17%.   More on Mid-day movers & stocks.  Seeking Alpha’s Quant Rating on Barinthus Biotherapeutics Historical earnings data for Barinthus Biotherapeutics Financial information for Barinthus Biotherapeutics Seeking Alpha’s Quant Rating on KWESST Micro Systems Historical earnings data for KWESST Micro Systems","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4087355-brns-upc-and-kwe-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2424390770","title":"ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2424390770","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424390770?lang=en_us&edition=fundamental","pubTime":"2024-04-04 22:00","pubTimestamp":1712239216,"startTime":"0","endTime":"0","summary":"Gainers: TC Biopharm ADR  +144%. Allurion Technologies  +65%. Tevogen Bio Holdings  +64%. Candel Therapeutics  +34%. MacroGenics  +28%.  Losers: eFFECTOR Therapeutics  -81%. Achilles Therapeutics ADR  -24%. Flora Growth  -15%. MSP Recovery  -11%. ARCA biopharma  -9%.   S&P 500 Health Care Sector +0.45% to 1687.02. Health Care Equipment & Services +0.43% to 1950.98. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.49% to 1385.84.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4087277-arca-biopharma-achilles-therapeutics-msp-recovery-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2424952353","title":"EC, ABAT and BORR among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2424952353","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424952353?lang=en_us&edition=fundamental","pubTime":"2024-04-04 20:25","pubTimestamp":1712233540,"startTime":"0","endTime":"0","summary":"Losers: Keyarch Acquisition Corp  -25%. Globavend Holdings Limited  -22%. LAMF Global Ventures Corp I  -21%. Flora Growth Corp  -19% on 20% share offering. Riley Exploration Permian  -17% after pricing $18.9M equity raise. GCT Semiconductor Holding  -11%. Achilles Therapeutics Plc  -11% reports fourth quarter and year-end 2023 financial results and recent business highlights.  XTI Aerospace  -8%. OneMedNet Corp.  -6%. ARCA biopharma  -6%. American Battery Technology Company  -6%. Helius Medical Technologies  -6%. MSP Recovery  -6%. Canopy Growth Corporation  -6%. Ecopetrol  -5%. Jiuzi Holdings  -5%. Borr Drilling Ltd  -5%.   More on Pre-market losers & stocks.  Borr Drilling: Downgrading On Potential Saudi Aramco Jackup Market Impact Borr Drilling: Fundamentals Remain Strong Ecopetrol Pays Out 18% Yield With Successful Permian Play And Gas Exploration American Battery Technology secures $20M tax credit through competitive U.S. DOE process Mexico said to cut some oil exports as global s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4087194-ec-abat-and-borr-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2405930417","title":"Iovance: Approval For Historic Solid Tumor Targeting TIL Therapy Likely, Outlook Promising","url":"https://stock-news.laohu8.com/highlight/detail?id=2405930417","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2405930417?lang=en_us&edition=fundamental","pubTime":"2024-01-22 01:04","pubTimestamp":1705856680,"startTime":"0","endTime":"0","summary":"Iovance's tumor infiltrating lymphocyte cell therapy candidate, lifileucel, has shown promising results in a study of melanoma patients, with a 31.4% overall response rate.Lifileucel uses a novel mech","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1397412703/image_1397412703.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1397412703/image_1397412703.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4664069-iovance-approval-for-historic-solid-tumor-targeting-til-therapy-likely-outlook-promising","is_publish_highlight":false,"gpt_icon":0},{"id":"2389793786","title":"Tracking Baker Brothers Portfolio - Q3 2023 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2389793786","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2389793786?lang=en_us&edition=fundamental","pubTime":"2023-12-05 10:29","pubTimestamp":1701743375,"startTime":"0","endTime":"0","summary":"Baker Brothers' 13F portfolio value increased marginally from $17.28B to $17.35B.The largest five stakes in the portfolio are Seagen, BeiGene, Incyte, ACADIA Pharma, and BioMarin Pharma, making up app","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160060870/image_1160060870.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160060870/image_1160060870.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4655920-tracking-baker-brothers-portfolio-q3-2023-update","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.achillestx.com","stockEarnings":[{"period":"1week","weight":0.0072},{"period":"1month","weight":-0.3445},{"period":"3month","weight":-0.2073},{"period":"6month","weight":-0.0965},{"period":"1year","weight":-0.0444},{"period":"ytd","weight":-0.1226}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.060793},{"month":2,"riseRate":0.333333,"avgChangeRate":0.059168},{"month":3,"riseRate":0,"avgChangeRate":-0.098119},{"month":4,"riseRate":0,"avgChangeRate":-0.20962},{"month":5,"riseRate":0.75,"avgChangeRate":0.045791},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.090554},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.104484},{"month":8,"riseRate":0.666667,"avgChangeRate":0.072029},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.032074},{"month":10,"riseRate":0,"avgChangeRate":-0.137556},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.054095},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.165277}],"exchange":"NASDAQ","name":"Achilles Therapeutics plc","nameEN":"Achilles Therapeutics plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Achilles Therapeutics plc(ACHL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Achilles Therapeutics plc(ACHL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Achilles Therapeutics plc,ACHL,Achilles Therapeutics plc股票,Achilles Therapeutics plc股票老虎,Achilles Therapeutics plc股票老虎国际,Achilles Therapeutics plc行情,Achilles Therapeutics plc股票行情,Achilles Therapeutics plc股价,Achilles Therapeutics plc股市,Achilles Therapeutics plc股票价格,Achilles Therapeutics plc股票交易,Achilles Therapeutics plc股票购买,Achilles Therapeutics plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Achilles Therapeutics plc(ACHL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Achilles Therapeutics plc(ACHL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction